Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02FWT
|
|||
Drug Name |
PMID28447479-Compound-14
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
PHARMAKEA, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H27FN4O4
|
|||
Canonical SMILES |
CC1(C2C(=O)N(C(=O)N2CC3=C1C4=C(N3CC5=CC=C(C=C5)F)N=CC=C4)CC(C)(C)C(=O)O)C
|
|||
InChI |
1S/C26H27FN4O4/c1-25(2,23(33)34)14-31-22(32)20-26(3,4)19-17-6-5-11-28-21(17)29(18(19)13-30(20)24(31)35)12-15-7-9-16(27)10-8-15/h5-11,20H,12-14H2,1-4H3,(H,33,34)
|
|||
InChIKey |
PZDULKFJLQEMQQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Extracellular lysophospholipase D (E-NPP2) | Target Info | Inhibitor | [1] |
Target's Patent Info | Extracellular lysophospholipase D (E-NPP2) | Target's Patent Info | [1] | |
KEGG Pathway | Ether lipid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.